An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables: Outline of the protocol
- 30 June 1999
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 59 (6) , 345-355
- https://doi.org/10.1016/s0010-7824(99)00044-x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Coagulation effects of oral contraceptionPublished by Elsevier ,2014
- Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control studyBMJ, 1996
- Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic diseaseThe Lancet, 1995
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Oral Contraceptive Estrogen Dose and the Risk of Deep Venous Thromboembolic DiseaseAmerican Journal of Epidemiology, 1991
- Oral contraceptives and venous thromboembolism: findings in a large prospective study.BMJ, 1986
- Oral contraceptives and blood coagulation: A critical reviewAmerican Journal of Obstetrics and Gynecology, 1982
- ORAL CONTRACEPTIVES AND THROMBOEMBOLIC DISEASE: EFFECTS OF LOWERING ŒSTROGEN CONTENTThe Lancet, 1980
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970